Idiopathic combined, autoantibody-mediated ADAMTS-13/factor H deficiency in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome in a 17-year-old woman: a case report
<p>Abstract</p> <p>Introduction</p> <p>Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome is a life-threatening condition with various etiopathogeneses. Without therapy approximately 90% of all patients die from the disease.</p> <p>Case presentati...
Main Authors: | Patschan Daniel, Korsten Peter, Behlau Arne, Vasko Radovan, Heeg Malte, Sweiss Nadera, Müller Gerhard A, Koziolek Michael |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-12-01
|
Series: | Journal of Medical Case Reports |
Online Access: | http://www.jmedicalcasereports.com/content/5/1/598 |
Similar Items
-
Pathogenicity of Anti-ADAMTS13 Autoantibodies in Acquired Thrombotic Thrombocytopenic Purpura
by: Mari R. Thomas, et al.
Published: (2015-08-01) -
Diagnostic relevance of ADAMTS13 activity: Evaluation of 28 patients with thrombotic thrombocytopenic purpura - hemolytic uremic syndrome clinical diagnosis
by: Vučelić Dragica, et al.
Published: (2013-01-01) -
Thrombotic microangiopathy in children: Redefining hemolytic uremic syndrome, thrombotic thrombocytopenic purpura and related disorders
by: Mamta Manglani, et al.
Published: (2024-03-01) -
Immune thrombotic thrombocytopenic purpura: Personalized therapy using ADAMTS‐13 activity and autoantibodies
by: Francesca Palandri, et al.
Published: (2021-12-01) -
Post-cardiac surgery thrombotic thrombocytopenic purpura: presence of anti-ADAMTS13 autoantibodies at preoperative baseline
by: Bryan Tordon, et al.
Published: (2022-04-01)